{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:06:00Z","timestamp":1783681560367,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Applied Basic Research Programs of Science and Technology Commission Foundation of Jiangsu Province","award":["BK20220201"],"award-info":[{"award-number":["BK20220201"]}]},{"name":"the National Key Research and Development Program of China","award":["2021YFC2700402"],"award-info":[{"award-number":["2021YFC2700402"]}]},{"name":"Jiangsu Provincial Science, Technology Department Social Development Surface Program","award":["BE2021743"],"award-info":[{"award-number":["BE2021743"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-025-07977-w","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:30:14Z","timestamp":1739907014000},"page":"197-205","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors, pregnancy outcomes, and management associated with non-reportable results in prenatal cell-free DNA testing"],"prefix":"10.1007","volume":"312","author":[{"given":"Hailing","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"7977_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008704","author":"S Chandrasekharan","year":"2014","unstructured":"Chandrasekharan S, Minear MA, Hung A et al (2014) Noninvasive prenatal testing goes global. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.3008704","journal-title":"Sci Transl Med"},{"issue":"3","key":"7977_CR2","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/uog.17484","volume":"50","author":"MM Gil","year":"2017","unstructured":"Gil MM, Accurti V, Santacruz B et al (2017) Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 50(3):302\u2013314. https:\/\/doi.org\/10.1002\/uog.17484","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"7977_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/pd.4804","volume":"36","author":"Y Yaron","year":"2016","unstructured":"Yaron Y (2016) The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon. Prenat Diagn 36(5):391\u2013396. https:\/\/doi.org\/10.1002\/pd.4804","journal-title":"Prenat Diagn"},{"issue":"2","key":"7977_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/pd.5408","volume":"39","author":"N Suzumori","year":"2019","unstructured":"Suzumori N, Sekizawa A, Takeda E et al (2019) Classification of factors involved in nonreportable results of noninvasive prenatal testing (NIPT) and prediction of success rate of second NIPT. Prenat Diagn 39(2):100\u2013106. https:\/\/doi.org\/10.1002\/pd.5408","journal-title":"Prenat Diagn"},{"issue":"1","key":"7977_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tjog.2019.11.003","volume":"59","author":"O Samura","year":"2020","unstructured":"Samura O, Okamoto A (2020) Causes of aberrant non-invasive prenatal testing for aneuploidy: a systematic review. Taiwan J Obstet Gynecol 59(1):16\u201320. https:\/\/doi.org\/10.1016\/j.tjog.2019.11.003","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"9","key":"7977_CR6","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/gim.2017.219","volume":"20","author":"DW Bianchi","year":"2018","unstructured":"Bianchi DW (2018) Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results. Genet Med 20(9):910\u2013917. https:\/\/doi.org\/10.1038\/gim.2017.219","journal-title":"Genet Med"},{"issue":"7","key":"7977_CR7","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/1471-0528.15006","volume":"125","author":"N Chan","year":"2017","unstructured":"Chan N, Smet ME, Sandow R et al (2017) Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study. BJOG: Int J Obstetr Gynaecol 125(7):848\u2013855. https:\/\/doi.org\/10.1111\/1471-0528.15006","journal-title":"BJOG: Int J Obstetr Gynaecol"},{"issue":"3","key":"7977_CR8","doi-asserted-by":"publisher","first-page":"300.e1","DOI":"10.1016\/j.ajog.2023.03.026","volume":"229","author":"ME Norton","year":"2023","unstructured":"Norton ME, MacPherson C, Demko Z et al (2023) Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results. Am J Obstet Gynecol 229(3):300.e1-300.e9. https:\/\/doi.org\/10.1016\/j.ajog.2023.03.026","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"7977_CR9","doi-asserted-by":"publisher","first-page":"168.e1","DOI":"10.1016\/j.ajog.2023.01.007","volume":"229","author":"K Bellai-Dussault","year":"2023","unstructured":"Bellai-Dussault K, Meng L, Howley H et al (2023) Cytogenetic outcomes following a failed cell-free DNA screen: a population-based retrospective cohort study of 35,146 singleton pregnancies. Am J Obstet Gynecol 229(2):168.e1-168.e8. https:\/\/doi.org\/10.1016\/j.ajog.2023.01.007","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"7977_CR10","doi-asserted-by":"publisher","first-page":"244.e1","DOI":"10.1016\/j.ajog.2023.12.008","volume":"231","author":"EC Becking","year":"2024","unstructured":"Becking EC, Scheffer PG, Henrichs J et al (2024) Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women. Am J Obstet Gynecol 231(2):244.e1-244.e18. https:\/\/doi.org\/10.1016\/j.ajog.2023.12.008","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"7977_CR11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/pd.6028","volume":"41","author":"PG Scheffer","year":"2021","unstructured":"Scheffer PG, Wirjosoekarto SAM, Becking EC et al (2021) Association between low fetal fraction in cell-free DNA testing and adverse pregnancy outcome: a systematic review. Prenat Diagn 41(10):1287\u20131295. https:\/\/doi.org\/10.1002\/pd.6028","journal-title":"Prenat Diagn"},{"issue":"6","key":"7977_CR12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/uog.15851","volume":"47","author":"R Revello","year":"2016","unstructured":"Revello R, Sarno L, Ispas A et al (2016) Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result. Ultrasound Obstet Gynecol 47(6):698\u2013704. https:\/\/doi.org\/10.1002\/uog.15851","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"7977_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/pd.5620","volume":"40","author":"L Hui","year":"2019","unstructured":"Hui L, Bianchi DW (2019) Fetal fraction and noninvasive prenatal testing: what clinicians need to know. Prenat Diagn 40(2):155\u2013163. https:\/\/doi.org\/10.1002\/pd.5620","journal-title":"Prenat Diagn"},{"key":"7977_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1755-8794-5-57","volume":"5","author":"Y Xie","year":"2012","unstructured":"Xie Y, Yin J, Su B et al (2012) Noninvasive fetal trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies. BMC Med Genomics 5:57. https:\/\/doi.org\/10.1186\/1755-8794-5-57","journal-title":"BMC Med Genomics"},{"key":"7977_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1232","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Chai X, Liu N et al (2020) FF-QuantSC: accurate quantification of fetal fraction by a neural network model. Mol Genet & Gen Med. https:\/\/doi.org\/10.1002\/mgg3.1232","journal-title":"Mol Genet & Gen Med"},{"key":"7977_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2022.100846","author":"JF Nitsche","year":"2023","unstructured":"Nitsche JF, Lovell D, Stephens N et al (2023) The effects of heparin, aspirin, and maternal clinical factors on the rate of nonreportable cell-free DNA results: a retrospective cohort study. Am J Obstet & Gynecol MFM. https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100846","journal-title":"Am J Obstet & Gynecol MFM"},{"issue":"1","key":"7977_CR17","doi-asserted-by":"publisher","first-page":"95.e1","DOI":"10.1016\/j.ajog.2023.07.005","volume":"230","author":"R Shree","year":"2024","unstructured":"Shree R, MacKinnon HJ, Hannan J et al (2024) Anticoagulation use is associated with lower fetal fraction and more indeterminate results. Am J Obstet Gynecol 230(1):95.e1-95.e10. https:\/\/doi.org\/10.1016\/j.ajog.2023.07.005","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"7977_CR18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/pd.5695","volume":"40","author":"N Nakamura","year":"2020","unstructured":"Nakamura N, Sasaki A, Mikami M et al (2020) Nonreportable rates and cell-free DNA profiles in noninvasive prenatal testing among women with heparin treatment. Prenat Diagn 40(7):838\u2013845. https:\/\/doi.org\/10.1002\/pd.5695","journal-title":"Prenat Diagn"},{"issue":"2","key":"7977_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/uog.17473","volume":"51","author":"GC Ma","year":"2018","unstructured":"Ma GC, Wu WJ, Lee MH et al (2018) Low-molecular-weight heparin associated with reduced fetal fraction and subsequent false-negative cell-free DNA test result for trisomy 21. Ultrasound Obstet Gynecol 51(2):276\u2013277. https:\/\/doi.org\/10.1002\/uog.17473","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"7977_CR20","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/uog.20290","volume":"53","author":"S Galeva","year":"2019","unstructured":"Galeva S, Gil MM, Konstantinidou L et al (2019) First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure. Ultrasound Obstet Gynecol 53(6):804\u2013809. https:\/\/doi.org\/10.1002\/uog.20290","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"7977_CR21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/humrep\/dey033","volume":"33","author":"TJ Lee","year":"2018","unstructured":"Lee TJ, Rolnik DL, Menezes MA et al (2018) Cell-free fetal DNA testing in singleton IVF conceptions. Hum Reprod 33(4):572\u2013578. https:\/\/doi.org\/10.1093\/humrep\/dey033","journal-title":"Hum Reprod"},{"issue":"2","key":"7977_CR22","doi-asserted-by":"publisher","first-page":"212.e1","DOI":"10.1016\/j.ajog.2015.03.032","volume":"213","author":"MS Lee","year":"2015","unstructured":"Lee MS, Cantonwine D, Little SE et al (2015) Angiogenic markers in pregnancies conceived through in vitro fertilization. Am J Obstet Gynecol 213(2):212.e1-212.e8. https:\/\/doi.org\/10.1016\/j.ajog.2015.03.032","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"7977_CR23","doi-asserted-by":"publisher","first-page":"417.e1","DOI":"10.1016\/j.ajog.2021.04.212","volume":"225","author":"MK Hopkins","year":"2021","unstructured":"Hopkins MK, Koelper N, Caldwell S et al (2021) Obesity and no call results: optimal timing of cell-free DNA testing and redraw. Am J Obstet Gynecol 225(4):417.e1-417.e10. https:\/\/doi.org\/10.1016\/j.ajog.2021.04.212","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"7977_CR24","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","volume":"136","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics, Committee on Genetics, & Society for Maternal-Fetal Medicine","year":"2020","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics, Committee on Genetics, & Society for Maternal-Fetal Medicine (2020) Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226. Obstet Gynecol 136(4):e48\u2013e69. https:\/\/doi.org\/10.1097\/AOG.0000000000004084","journal-title":"Obstet Gynecol"},{"key":"7977_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.11.004","author":"JS Dungan","year":"2023","unstructured":"Dungan JS, Klugman S, Darilek S et al (2023) Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. https:\/\/doi.org\/10.1016\/j.gim.2022.11.004","journal-title":"Genet Med"},{"issue":"8","key":"7977_CR26","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1007\/s43032-021-00656-6","volume":"29","author":"LM Coutinho","year":"2021","unstructured":"Coutinho LM, Assis WA, Spagnuolo-Souza A et al (2021) Uterine fibroids and pregnancy: how do they affect each other? Reprod Sci 29(8):2145\u20132151. https:\/\/doi.org\/10.1007\/s43032-021-00656-6","journal-title":"Reprod Sci"},{"issue":"4","key":"7977_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ajog.2023.11.1240","volume":"230","author":"Y Raymond","year":"2024","unstructured":"Raymond Y, Fernando S, Menezes M et al (2024) Placental, maternal, fetal, and technical origins of false-positive cell-free DNA screening results. Am J Obstet Gynecol 230(4):381\u2013389. https:\/\/doi.org\/10.1016\/j.ajog.2023.11.1240","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"7977_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/uog.29098","volume":"64","author":"DL Rolnik","year":"2024","unstructured":"Rolnik DL, Raymond Y, Lee T et al (2024) Uterine fibroids and non-informative cell-free DNA screening results. Ultrasound Obstet Gynecol 64(4):463\u2013469. https:\/\/doi.org\/10.1002\/uog.29098","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"22","key":"7977_CR29","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1200\/JCO.21.02260","volume":"40","author":"CJ Heesterbeek","year":"2022","unstructured":"Heesterbeek CJ, Aukema SM, Galjaard RH et al (2022) Noninvasive prenatal test results indicative of maternal malignancies: a nationwide genetic and clinical follow-up study. J Clin Oncol\u202f: Off J Am Soc Clin Oncol 40(22):2426\u20132435. https:\/\/doi.org\/10.1200\/JCO.21.02260","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-07977-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-07977-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-07977-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T06:11:53Z","timestamp":1750227113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-07977-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["7977"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-07977-w","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors state no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was reviewed and approved by the Ethics Committee of First Affiliated Hospital of Nanjing Medical University (approval number: 2024-SR-049).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients signed informed consent regarding publishing their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent was obtained from all participants included in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}